Glecaprevir Impurity 2 | CAS 32897-26-0 - Request Quote
Glecaprevir Impurity 2
| SZ CAT No: | SZ-G038003 |
| CAS No | 32897-26-0 |
| Mol.F. | C8H19N3O |
| Mol.Wt. | 173.3 |
| Inv. Status | In Stock |
| Rel. CAS No | 4607-26-5 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Glecaprevir Impurity 2 is chemically 1-[3-(Dimethyl amino) propyl]-3-ethylurea. Glecaprevir Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Glecaprevir Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Glecaprevir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 32897-26-0
Purchase 32897-26-0
Order 32897-26-0
Enquire 32897-26-0
price of 32897-26-0
32897-26-0 Supplier
32897-26-0 Manufacturer
32897-26-0 Exporter
buy high quality Glecaprevir Impurity 2
Purchase Glecaprevir Impurity 2
Glecaprevir Impurity 2 suppliers
Glecaprevir Impurity 2 manufacturers
Glecaprevir Impurity 2 price
Order Glecaprevir Impurity 2
Enquire Glecaprevir Impurity 2
Glecaprevir Impurity 2 cost
Glecaprevir Impurity 2 Supplier
Glecaprevir Impurity 2 Distributor
Glecaprevir Impurity 2 for Method Validation
Glecaprevir Reference Standard
Glecaprevir Impurity 2 for ANDA Filing
Glecaprevir Impurity 2 for Forced Degradation Studies
Glecaprevir Impurity 2 Identification Standards
Glecaprevir Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.